BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30843171)

  • 1. Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy.
    Giorgio A; Amendola F; Calvanese A; Ingenito E; Santoro B; Gatti P; Ciracì E; Matteucci P; Giorgio V
    J Ultrasound; 2019 Mar; 22(1):53-58. PubMed ID: 30843171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumors.
    Sugimoto K; Moriyasu F; Saito K; Kobayashi Y; Itoi T
    J Med Ultrason (2001); 2017 Jul; 44(3):247-254. PubMed ID: 27933441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients.
    Niessen C; Beyer LP; Pregler B; Dollinger M; Trabold B; Schlitt HJ; Jung EM; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2016 Apr; 27(4):480-6. PubMed ID: 26922979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
    Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
    Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
    J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
    Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
    PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
    Dollinger M; Jung EM; Beyer L; Niessen C; Scheer F; Müller-Wille R; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2014 Oct; 25(10):1589-94. PubMed ID: 25156648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
    Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
    BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a robotic system for irreversible electroporation (IRE) of malignant liver tumors: initial results.
    Beyer LP; Pregler B; Michalik K; Niessen C; Dollinger M; Müller M; Schlitt HJ; Stroszczynski C; Wiggermann P
    Int J Comput Assist Radiol Surg; 2017 May; 12(5):803-809. PubMed ID: 27653615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
    Kingham TP; Karkar AM; D'Angelica MI; Allen PJ; Dematteo RP; Getrajdman GI; Sofocleous CT; Solomon SB; Jarnagin WR; Fong Y
    J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
    Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
    Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings.
    Granata V; Fusco R; Catalano O; Piccirillo M; De Bellis M; Izzo F; Petrillo A
    AJR Am J Roentgenol; 2015 May; 204(5):1000-7. PubMed ID: 25905934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local control of perivascular malignant liver lesions using percutaneous irreversible electroporation: initial experiences.
    Eller A; Schmid A; Schmidt J; May M; Brand M; Saake M; Uder M; Lell M
    Cardiovasc Intervent Radiol; 2015 Feb; 38(1):152-9. PubMed ID: 24798135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety.
    Wang Z; Lu J; Huang W; Wu Z; Gong J; Wang Q; Liu Q; Wang C; Zhu Y; Ding X; Wang Z
    BMC Cancer; 2021 Feb; 21(1):124. PubMed ID: 33546635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Meijerink MR; Ruarus AH; Vroomen LGPH; Puijk RS; Geboers B; Nieuwenhuizen S; van den Bemd BAT; Nielsen K; de Vries JJJ; van Lienden KP; Lissenberg-Witte BI; van den Tol MP; Scheffer HJ
    Radiology; 2021 May; 299(2):470-480. PubMed ID: 33724066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Irreversible Electroporation (IRE) of Hepatic Malignancy: A Bi-institutional Analysis of Safety and Outcomes.
    Mafeld S; Wong JJ; Kibriya N; Stenberg B; Manas D; Bassett P; Aslam T; Evans J; Littler P
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):577-583. PubMed ID: 30465255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound and Contrast-enhanced Ultrasound Findings after Percutaneous Irreversible Electroporation of Hepatic Malignant Tumors.
    Chai W; Xie L; Zhao Q; Cheng C; Tian G; Jiang T; Wu P
    Ultrasound Med Biol; 2020 Mar; 46(3):620-629. PubMed ID: 31924420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent Colorectal Liver Metastases in the Liver Remnant After Major Liver Surgery-IRE as a Salvage Local Treatment When Resection and Thermal Ablation are Unsuitable.
    Hitpass L; Distelmaier M; Neumann UP; Schöning W; Isfort P; Keil S; Kuhl CK; Bruners P; Barabasch A
    Cardiovasc Intervent Radiol; 2022 Feb; 45(2):182-189. PubMed ID: 34757483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.